Weight-loss treatments are on the cusp of a revolution, and could benefit large numbers of Indians after the main patent ...

Novo's Ozempic is approved by the U.S. Food and Drug Administration ... This year, the FDA approved the company's Alzheimer's ...

Euronews Health looks at some of this year’s top medical advances and the key areas of health that were the most solicited ...

Scientists believe the weight-loss jab's role in reducing inflammation in the body is key as this is common to other ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

GLP-1 inhibitor drugs might affect everything from food noise to Alzheimer's. Experts answer your top questions about their ...

There have been several developments in glucagon-like peptide-1 receptor agonists (GLP-1RAs), with both Novo Nordisk and Eli ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

Novo Nordisk could also post results for semaglutide, the active ingredient in Wegovy and Ozempic, in treating patients with ...